Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
-
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
-
Huntress Recognized as Inc. 2024 Power Partner for Empowering Small and Mid-Sized Businesses with Cutting-Edge Cybersecurity Protection
-
Blade Air Mobility to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
PodcastOne (PODC) Unveils Explosive 10th Season of The Opportunist: "Tim Ballard: Unmasking a Hero" - Exposing Dark Allegations
-
Guess What? Nobody and Everybody Cares About AI
-
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
-
Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024
-
Crunchtime Unveils AI Forecasting
-
Arteris to Announce Financial Results for the Third Quarter 2024 on Tuesday, November 5, 2024
-
Reminder: Program for the publication of Yara International ASA third quarter results 2024
-
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
-
ThreatQuotient Unites Cybersecurity Leaders for a Week of In-Depth Threat Intelligence Exploration
-
Exo Therapeutics Announces Late Breaking Poster at American College of Rheumatology’s Convergence (ACR)
-
Waze Co-founder and former Infosys board member, Uri Levine, Returns to Zoomcar in Strategic Advisory Role
-
Guide Outdoor Releases the Powerhouse TS Gen2 Series Built for Hunting
-
Aurachain Unveils Advanced AI Features to Transform Organizations and Drive ROI
-
CLEAN EATZ CELEBRATES Q3 ACHIEVEMENTS AND FRANCHISEE SUCCESS AT 2024 ANNUAL CONVENTION
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
TRU Provides Update on Flagship Golden Rose Project
-
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, f
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
ProTek Devices' New Set of TVS Devices Deliver MIL-STD Grade Circuit Protection in Aircrafts
-
Syra Health To Discuss Third Quarter 2024 Financial Results
-
Blackbridge Investment Group (BIG) Announces Innovative Revenue-Based Financing Solution
-
SediVision Announces Newly Designed Website to Better Serve Wastewater Industry Professionals
-
Pasofino Gold Provides Update on Non-Brokered Private Placement
-
Autobrains Unveils Skills Product Line, Redefining Autonomous Driving With Scalable and Modular AI Solutions
-
Stillwater Critical Minerals to Present at the Emerging Growth Conference on October 30th
-
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
-
Frontera Announces Completion of Substantial Issuer Bid
-
TECNO Reveals Winners of Shot On CAMON Photography Contest 2024
-
International SOS Foundation Launches Risk Management Support for Educational Trip Organisers
-
Affinia Therapeutics to Highlight New Data on Genetic Cardiomyopathy Programs and BBB-Penetrant Capsids Leveraging Novel Receptors at the European Society of Gene & Cell Therapy 2024 31st Annual C
-
US Bureau of Reclamation Selects Jacobs to Design and Build Critical New Mexico Water Project
-
Glendale Area Schools Credit Union Selects Mahalo Banking to Optimize Digital Banking Capabilities
-
Interactive Brokers Group Issues Form 8-K/A Disclosing Revised Operating Results for 3Q2024
-
Marex Group Plc to Announce Third Quarter 2024 Earnings on November 7, 2024
-
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
-
New Novel Explores High School Peer Pressure, Faith and the Struggle to Preserve Chastity
-
CEO Alona Shevtsova: Leo Messenger to debut at Sigma Europe Conference 2024 in Valletta
-
Sify reports Consolidated Financial Results for Q2 FY 2024-25
-
Farrow & Ball Partners with Proximity to Elevate Customer Experience through Innovative Digital Tools
-
Toobit Leads Conversations on Blockchain Innovation at Future Blockchain Summit 2024
-
Atlas Salt Commences Geotechnical Drilling Program and Finalizes 160 Hectare Crown Land Surface Lease for Great Atlantic Salt Project
-
GeoPark Argentina Obtains AA+(arg) Credit Rating and Approval From Argentine Regulator to Issue up to $500 Million in Debt Securities
-
Myriad Uranium's First Ten Boreholes at Copper Mountain Intercept High Grade Mineralisation, Provide Strong Validation of Historic Work
-
Appia Announces Non-Brokered Private Placement
-
Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites
